Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD8+ T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age.
Menon T, Illing PT, Chaurasia P, McQuilten HA, Shepherd C, Rowntree LC, Petersen J, Littler DR, Khuu G, Huang Z, Allen LF, Rockman S, Crowe J, Flanagan KL, Wakim LM, Nguyen THO, Mifsud NA, Rossjohn J, Purcell AW, van de Sandt CE, Kedzierska K. Menon T, et al. Among authors: allen lf. Nat Commun. 2024 Apr 29;15(1):3387. doi: 10.1038/s41467-024-47576-y. Nat Commun. 2024. PMID: 38684663 Free PMC article.
Immunoglobulin G genetic variation can confound assessment of antibody levels via altered binding to detection reagents.
Purcell RA, Aurelia LC, Esterbauer R, Allen LF, Bond KA, Williamson DA, Trevillyan JM, Trubiano JA, Juno JJ, Wheatley AK, Davenport MP, Nguyen TH, Kedzierska K, Kent SJ, Selva KJ, Chung AW. Purcell RA, et al. Among authors: allen lf. Clin Transl Immunology. 2024 Feb 29;13(3):e1494. doi: 10.1002/cti2.1494. eCollection 2024. Clin Transl Immunology. 2024. PMID: 38433763 Free PMC article.
Evolution of Humoral and Cellular Immunity Post-Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving Tixagevimab-Cilgavimab.
Hall VG, Nguyen THO, Allen LF, Rowntree LC, Kedzierski L, Chua BY, Lim C, Saunders NR, Klimevski E, Tennakoon GS, Seymour JF, Wadhwa V, Cain N, Vo KL, Nicholson S, Karapanagiotidis T, Williamson DA, Thursky KA, Spelman T, Yong MK, Slavin MA, Kedzierska K, Teh BW. Hall VG, et al. Among authors: allen lf. Open Forum Infect Dis. 2023 Nov 2;10(11):ofad550. doi: 10.1093/ofid/ofad550. eCollection 2023 Nov. Open Forum Infect Dis. 2023. PMID: 38023562 Free PMC article.
Interim results from a phase I randomized, placebo-controlled trial of novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as a 4th dose booster.
Nolan TM, Deliyannis G, Griffith M, Braat S, Allen LF, Audsley J, Chung AW, Ciula M, Gherardin NA, Giles ML, Gordon TP, Grimley SL, Horng L, Jackson DC, Juno JA, Kedzierska K, Kent SJ, Lewin SR, Littlejohn M, McQuilten HA, Mordant FL, Nguyen THO, Soo VP, Price B, Purcell DFJ, Ramanathan P, Redmond SJ, Rockman S, Ruan Z, Sasadeusz J, Simpson JA, Subbarao K, Fabb SA, Payne TJ, Takanashi A, Tan CW, Torresi J, Wang JJ, Wang LF, Al-Wassiti H, Wong CY, Zaloumis S, Pouton CW, Godfrey DI. Nolan TM, et al. Among authors: allen lf. EBioMedicine. 2023 Dec;98:104878. doi: 10.1016/j.ebiom.2023.104878. Epub 2023 Nov 27. EBioMedicine. 2023. PMID: 38016322 Free PMC article. Clinical Trial.
Broad spectrum SARS-CoV-2-specific immunity in hospitalized First Nations peoples recovering from COVID-19.
Zhang W, Clemens EB, Kedzierski L, Chua BY, Mayo M, Lonzi C, Hinchcliff A, Rigas V, Middleton BF, Binks P, Rowntree LC, Allen LF, Tan HX, Petersen J, Chaurasia P, Krammer F, Wheatley AK, Kent SJ, Rossjohn J, Miller A, Lynar S, Nelson J, Nguyen TH, Davies J, Kedzierska K. Zhang W, et al. Among authors: allen lf. Immunol Cell Biol. 2023 Nov-Dec;101(10):964-974. doi: 10.1111/imcb.12691. Epub 2023 Sep 19. Immunol Cell Biol. 2023. PMID: 37725525
55 results